Navigation Links
Sunridge Signs Distribution Agreement for Turkey
Date:2/23/2011

FOUNTAIN HILLS, Ariz., Feb. 23, 2011 /PRNewswire/ -- Sunridge International (OTC Bulletin Board/OTCQB: SNDZ), announced today the signing of an exclusive distribution contract for Turkey.  Based on Turkey's population of approximately 75 million people, the 5-year contract with New Amsterdam Marketing Corporation, should provide a substantial increase in sales.  Preparations are currently being made for Sunridge to send medical personnel to train local key opinion leaders to assist New Amsterdam's marketing rollout.

Sunridge's CEO, G. Richard Smith stated, "Our goal has always been to expand our distribution network.  With the signing of this agreement, along with the distribution rights to several additional countries throughout Europe that we are currently negotiating, we are very pleased with the progress that we are making."  

"Recently we expanded our business model to include the addition of company owned clinics, which is a more aggressive approach for Sunridge.  Our funding efforts for the clinics is progressing well at this time, and we look forward to advancing into this highly profitable market."

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International www.oi-pnt.com.CONTACT:Jeff Smith of Sunridge InternationalT: +1-480-837-6165e-mail: info@sunridgeint.comMEDIA:Victor Webb of Marston Webb InternationalT: +1-212-684-6601e-mail: marwebint@cs.com
'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
2. Sunridge Schedules European Meetings
3. Sunridge Ships First Order to the Middle East
4. Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India
5. Sunridge Advances its PNT Glaucoma Treatment Throughout China
6. Sunridge Receives Reorder on $4 Million Indian Contract
7. Sunridge Schedules Public Conference Call
8. Sunridge Middle East Distributor to Begin Clinical Trials Necessary for Reimbursement
9. Sunridge Moves Forward to Open Company Owned Clinics
10. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
11. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after thirteen ... in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl appearances ... yards by a quarterback (6,109) and the most rushing yards by a quarterback in ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Sean Fay ... Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold ... any other marketer in the last 25 years. , Now, due to changes in ...
Breaking Medicine News(10 mins):